| Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey EA Karanges, A Suraev, N Elias, R Manocha, IS McGregor BMJ open 8 (7), e022101, 2018 | 137 | 2018 |
| Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies AS Suraev, NS Marshall, R Vandrey, D McCartney, MJ Benson, ... Sleep medicine reviews 53, 101339, 2020 | 125 | 2020 |
| Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18) N Lintzeris, L Mills, A Suraev, M Bravo, T Arkell, JC Arnold, MJ Benson, ... Harm reduction journal 17, 1-12, 2020 | 97 | 2020 |
| An Australian nationwide survey on medicinal cannabis use for epilepsy: history of antiepileptic drug treatment predicts medicinal cannabis use AS Suraev, L Todd, MT Bowen, DJ Allsop, IS McGregor, C Ireland, ... Epilepsy & Behavior 70, 334-340, 2017 | 79 | 2017 |
| Cannabidiol and sports performance: a narrative review of relevant evidence and recommendations for future research D McCartney, MJ Benson, B Desbrow, C Irwin, A Suraev, IS McGregor Sports medicine-open 6, 1-18, 2020 | 76 | 2020 |
| Composition and use of cannabis extracts for childhood epilepsy in the Australian community A Suraev, N Lintzeris, J Stuart, RC Kevin, R Blackburn, E Richards, ... Scientific reports 8 (1), 10154, 2018 | 71 | 2018 |
| Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding J Russell, S Maguire, GE Hunt, A Kesby, A Suraev, J Stuart, J Booth, ... Psychoneuroendocrinology 87, 83-92, 2018 | 68 | 2018 |
| Adolescent pre‐treatment with oxytocin protects against adult methamphetamine‐seeking behavior in female rats C Hicks, JL Cornish, SJ Baracz, A Suraev, IS McGregor Addiction biology 21 (2), 304-315, 2016 | 56 | 2016 |
| Active coping toward predatory stress is associated with lower corticosterone and progesterone plasma levels and decreased methylation in the medial amygdala vasopressin system MT Bowen, SAH Dass, J Booth, A Suraev, A Vyas, IS McGregor Hormones and behavior 66 (3), 561-566, 2014 | 50 | 2014 |
| Adolescent exposure to oxytocin, but not the selective oxytocin receptor agonist TGOT, increases social behavior and plasma oxytocin in adulthood AS Suraev, MT Bowen, SO Ali, C Hicks, L Ramos, IS McGregor Hormones and behavior 65 (5), 488-496, 2014 | 43 | 2014 |
| Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting J Johnston, N Lintzeris, DJ Allsop, A Suraev, J Booth, DS Carson, ... Psychopharmacology 231, 4623-4636, 2014 | 39 | 2014 |
| Chronic methamphetamine self‐administration dysregulates oxytocin plasma levels and oxytocin receptor fibre density in the nucleus accumbens core and subthalamic nucleus of the rat SJ Baracz, LM Parker, AS Suraev, NA Everett, AK Goodchild, IS McGregor, ... Journal of neuroendocrinology 28 (4), 2016 | 38 | 2016 |
| Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of … A Suraev, RR Grunstein, NS Marshall, AL D'Rozario, CJ Gordon, ... BMJ open 10 (5), e034421, 2020 | 36 | 2020 |
| Driving-related behaviours, attitudes and perceptions among Australian medical cannabis users: results from the CAMS 18-19 survey TR Arkell, N Lintzeris, L Mills, A Suraev, JC Arnold, IS McGregor Accident Analysis & Prevention 148, 105784, 2020 | 34 | 2020 |
| Effects of cannabidiol on simulated driving and cognitive performance: a dose-ranging randomised controlled trial D McCartney, AS Suraev, PT Doohan, C Irwin, RC Kevin, RR Grunstein, ... Journal of psychopharmacology 36 (12), 1338-1349, 2022 | 31 | 2022 |
| The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence JC Arnold, D McCartney, A Suraev, IS McGregor Clinical and translational science 16 (1), 10-30, 2023 | 28 | 2023 |
| Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20) N Lintzeris, L Mills, SV Abelev, A Suraev, JC Arnold, IS McGregor Harm reduction journal 19 (1), 88, 2022 | 24 | 2022 |
| Medicinal cannabis for inflammatory bowel disease: a survey of perspectives, experiences, and current use in Australian patients MJ Benson, SV Abelev, SJ Connor, CJ Corte, LJ Martin, LK Gold, ... Crohn's & Colitis 360 2 (2), otaa015, 2020 | 23 | 2020 |
| The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol D McCartney, MJ Benson, AS Suraev, C Irwin, TR Arkell, RR Grunstein, ... Human Psychopharmacology: Clinical and Experimental 35 (5), e2749, 2020 | 20 | 2020 |
| Cannabinoids, insomnia, and other sleep disorders I Lavender, IS McGregor, A Suraev, RR Grunstein, CM Hoyos Chest 162 (2), 452-465, 2022 | 17 | 2022 |
